ConcertAI & Caris Life Sciences Expand Partnership

Learn More

ConcertAI & PathAI Partner Creating First-in-Class Histopathology and Curated Clinical RWD Product

Read More

ConcertAI and Caris Life Sciences Form Partnership Creating Industry’s Largest Molecular Oncology Research Biopharma Platform

Read More

Bristol Myers Squibb and ConcertAI Advance Novel Oncology Accelerated Digital Clinical Trial Solution

Learn More

QCCA and ConcertAI Partner on Novel Digital Clinical Trial Solutions

Learn More

ConcertAI Expands Partnership with Janssen Pharmaceuticals

Learn More

FDA Collaboration to Advance Use of RWE

Learn More


Promoting Cancer Health Equity

Learn More

Commercial Solutions to Increase Patient Adherence

Learn More


Making Equity and Trial Diversity Real

a Blog by Jeff Elton, CEO

Independent, Scalable and Specialized

The Industry’s Largest U.S. Oncology RWD

See Our Data

EMR Systems


AI Models


Medical Oncologists


Provider Cancer Clinics


Data Refreshes

The ConcertAI Podcast is now live! Listen on your preferred platform or click the link below.

Click to listen now!

See All Events

ICPE 2023

August 23, 2023

We’re excited to be attending ICPE 2023: The Global Home for the Science of Real-World Evidence this year in Halifax, Nova Scotia, Canada. The conference provides an international platform for the latest advancements and discussions on real-world data and its significant impacts on healthcare. Meet with one of ConcertAI’s team members to learn how our AI-driven real-world data solutions transform the way health data is analyzed and utilized. With our innovative AI solutions, ConcertAI is at the forefront of revolutionizing health and life sciences, bringing a new perspective to ICPE 2023.

Meet with Us

ESMO Congress 2023

October 20, 2023

As a healthcare industry representative, you won’t want to miss the opportunity to connect with ConcertAI at this event. ESMO 2023 will provide unparalleled networking opportunities for attendees from all around the world. Engage with our leading experts, stay up-to-date on emerging trends in oncology research, and build new partnerships that will drive innovation in your organization.

If you’re looking to expand your knowledge and make a real impact in the fight against cancer, meet with us at ESMO 2023. We’ll see you in Madrid!

Learn More

RSNA 2023

November 26, 2023

TeraRecon, a ConcertAI Company, will be attending this year’s Radiological Society of North America (RSNA) conference! Our goal is to connect with leading experts, share our cutting-edge imaging technologies, and stay updated with the latest trends in radiology. We’re excited about the opportunities this conference provides for networking, partnerships, and insights into the evolving role of AI in radiology.

Visit TeraRecon

65th ASH Annual Meeting and Exposition

December 9, 2023

As a leader in healthcare technology, we recognize the importance of staying up-to-date with the latest developments in classical and malignant hematology. The ASH Annual Meeting and Exposition is the premier event for hematology experts from around the world, and we are thrilled to be part of this comprehensive event.

We can’t wait to join the world’s leading hematology experts at the 65th ASH Annual Meeting and Exposition in San Diego. Mark your calendars now and we hope to see you there!

Learn More

SABCS 2023

December 5, 2023

ConcertAI is heading to SABCS 2023, a global symposium that’s at the forefront of breast cancer research and care. We look forward to immersing ourselves in expert lectures, presentations, and discussions on cutting-edge cancer science. Joining 9,500 attendees from over 100 countries, we’re ready to drive the future of healthcare with our AI-powered insights.

Click the link to set up a meeting with us in advance. Together, we can advance cancer care.

Meet with Us
Clinical Development

For Improved Patient Outcomes in Oncology

Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.
Our experienced team of scientists work with our data and AI technologies to accelerate trial data analysis and to help you implement novel data and analytics techniques for RCTs, pragmatic trials, external controls, or adaptive studies.

Drive Better
Patient Outcomes
for Diseases

Learn More
  • AML
  • Breast Cancer
  • Cirrhosis
  • Fabry Disease
  • GIST
  • Hemophilia
  • Hepatitis C
  • Leukemia
  • Multiple Sclerosis
  • Myelofibrosis
  • Plaque Psoriasis
  • Prostate Cancer
  • Pulmonary Arterial Hypertension
  • Rheumatoid Arthritis
  • Schizophrenia
  • Tardive Dyskinesia

Innovate with ConcertAI – We’re hiring!

Join the fastest growing AI-powered SaaS and data company in healthcare. We are looking for motivated, curious, independent people dedicated to transforming how healthcare is delivered. Talk to us about how to make an impact.